APA (7th ed.) Citation

Zhao, Y., Wang, H., & He, C. (2021). Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: From mechanism analysis to clinical strategy. Journal of cancer research and clinical oncology, 147(12), 3653-3664. https://doi.org/10.1007/s00432-021-03828-8

Chicago Style (17th ed.) Citation

Zhao, Yuxin, Haiyong Wang, and Chengwei He. "Drug Resistance of Targeted Therapy for Advanced Non-small Cell Lung Cancer Harbored EGFR Mutation: From Mechanism Analysis to Clinical Strategy." Journal of Cancer Research and Clinical Oncology 147, no. 12 (2021): 3653-3664. https://doi.org/10.1007/s00432-021-03828-8.

MLA (9th ed.) Citation

Zhao, Yuxin, et al. "Drug Resistance of Targeted Therapy for Advanced Non-small Cell Lung Cancer Harbored EGFR Mutation: From Mechanism Analysis to Clinical Strategy." Journal of Cancer Research and Clinical Oncology, vol. 147, no. 12, 2021, pp. 3653-3664, https://doi.org/10.1007/s00432-021-03828-8.